These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report. Friesen CM; Brodsky JB; Dillingham MF Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349 [TBL] [Abstract][Full Text] [Related]
10. Dantrolene sodium in the treatment of malignant hyperthermia. A case report. Harrison GG S Afr Med J; 1981 Dec; 60(23):909-10. PubMed ID: 7302773 [TBL] [Abstract][Full Text] [Related]
12. [Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia]. Lombertie ER; Durelle G; Fuseau A Ann Med Psychol (Paris); 1995 Oct; 153(8):531-4. PubMed ID: 8561400 [TBL] [Abstract][Full Text] [Related]
13. Treatment of clozapine-associated tardive dyskinesia. Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744 [No Abstract] [Full Text] [Related]
14. An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms. Waddington JL; Youssef HA Am J Psychiatry; 1986 Sep; 143(9):1162-5. PubMed ID: 2875664 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic-induced emesis: a new indication for clozapine? Bustillo JR; Buchanan RW Biol Psychiatry; 1995 Aug; 38(3):194-5. PubMed ID: 7578665 [No Abstract] [Full Text] [Related]
16. Heat stroke in schizophrenia during clozapine treatment: rapid recognition and management. Kerwin RW; Osborne S; Sainz-Fuertes R J Psychopharmacol; 2004 Mar; 18(1):121-3. PubMed ID: 15107195 [TBL] [Abstract][Full Text] [Related]
18. [Dimethylaminoethanol in the treatment of neuroleptic-induced tardive dyskinesia]. Lambert PA; Wolff P; de Maximy B; Ghenim A Ann Med Psychol (Paris); 1978 Apr; 136(4):625-9. PubMed ID: 31832 [No Abstract] [Full Text] [Related]